The size of the Home Healthcare Market in Europe was worth USD 70.28 billion in 2019 and estimated to be growing at a CAGR of 8.37 %; to reach USD 105.04 billion by 2024. The European Home Healthcare market has had immense development in the past few years, thanks to the rising aging population and advancements in technology. Europe region is accounted for as the second largest in the home healthcare market over the regional period. The growing aging population and advancements in technology drive the growth of the home healthcare market. Germany is predicted to have the largest share in the European home healthcare market and is expected to dominate the market throughout the period, which is next to France and the UK. German home healthcare market is expected to have the highest market due to the increasing amount spent on in-home healthcare and the growing demand for skilled nursing workers in-house.
Increasing incidences of chronic diseases is undoubtedly a significant factor for the home healthcare market to grow extensively in the European nations. Rise in demand to have personal caretakers after surgeries are accelerating the need for the market. Also, increasing funds from the private and public organizations in the medical sector are propelling the growth of the regional market.
However, lack of standardization is slightly to hinder the demand of the market. Stringent rules and regulations by the government may also negatively impact the growth of Europe's market.
Growth opportunities for the market lie in the rise in the government initiative in support of the home healthcare systems. Furthermore, the market is propelled by the increasing elderly population across the globe. Growing demand for cost-effectiveness healthcare is significantly influencing the growth of the market. The emergence of advanced technology and the launch of various systems in favor of the medical sector are leveraging market demand.
The growing number for long term care cases is also escalating the growth of the European market. Rising disposable income in urban areas is leveling up the demand of the market. The availability of healthcare systems at affordable home prices is surging the growth of the market.
Germany led the European home healthcare market in 2019. It resulted from the increase in the number of elderly individuals, the number of chronic diseases, government expenditure, awareness of new advances, attention to home healthcare, and reliable protection scope. France is the second-biggest home healthcare in Europe.
Europe Home Healthcare Market Report has been segmented and sub-segmented into the following categories.
REGIONAL ANALYSIS
The European home healthcare market is leading dominant shares in the global home healthcare market following North America.
Germany is the highest market for European home healthcare, followed by the U.K. and France. An increasing number of older people and technological advancement are significant factors for the growth of the German home healthcare market. The Russian market is expected to have substantial growth over the next five years. Home care product gives excellent treatment facility to the patient with good-quality home-based healthcare and social service. The key reason for the increasing growth of the European market is raising the geriatric population with diseases increased in several European countries.
An Overview of the Germany Home Healthcare Market
Germany took the highest market share in Europe, followed by France. This is due to rising spending toward in-home healthcare and increasing demand for skilled nursing workers in the house. A critical factor in the growth of the market has been rising healthcare costs, which transfer the focus of healthcare from hospital to home, and the Germany government took the initiative to support home healthcare further increases the market.
Russian home healthcare market is expected to have considerable growth in the next years due to excellent treatment given to the patient with a good quality home-based healthcare and social service, which serves as contributors to the market growth in this European region.
The home healthcare market in France is projected to have notable growth in this region. The growing aging population with the rising frequency of continuous diseases like diabetic foot ulcers fuel market growth. In the UK, nearly 3.31 million people are aged above 65years, which is 19.4% of the total population of the UK. Different benefits provided by healthcare technologies such as patient authorization in making them less dependent on healthcare professionals, upgraded quality of care in patients, easy accessibility, and reduced cost of care are likely to spur the home healthcare market growth in this European region.
Notable companies dominating in the Europe Home Healthcare Market Profiled in the Report are Almost Family Inc., Amedisys Inc., General Electric Company (GE), Kinnser Software Inc, Linde Group, Omron Corporation, Roche Holding AG, Philips Healthcare, Mckesson Corporation, LHC Group Inc, Kindred Healthcare, Fresenius Se & Co Kgaa, Abbott Laboratories, and Apria Healthcare Group.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Testing, Screening, & Monitoring Products
5.1.3 Therapeutic Products
5.1.4 Mobility Care Products
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Home Telehealth Monitoring Devices
5.2.3 Home Telehealth Services
5.2.4 Home Telehealth Software
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Software
5.3.1 Introduction
5.3.2 Agency Software
5.3.3 Clinical Management Systems
5.3.4 Hospice Solutions
5.3.5 Y-o-Y Growth Analysis, By Software
5.3.6 Market Attractiveness Analysis, By Software
5.3.7 Market Share Analysis, By Software
5.4 Services
5.4.1 Introduction
5.4.2 Rehabilitation Therapy Services
5.4.3 Infusion Therapy Services
5.4.4 Unskilled Care Services
5.4.5 Respiratory Therapy Services
5.4.6 Pregnancy Care Services
5.4.7 Skilled Nursing Care Services
5.4.8 Hospice
5.4.9 Palliative Care Services
5.4.7 Y-o-Y Growth Analysis, By Services
5.4.8 Market Attractiveness Analysis, By Services
5.4.9 Market Share Analysis, By Services
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Softwares
6.1.3.5 By Services
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Softwares
6.1.4.5 By Services
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By Softwares
6.1.5.5 By Services
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 of Home healthcare Market
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 A&D Company Limited
8.3 Almost Family Inc
8.4 Amedisys Inc
8.5 General Electric Company (GE)
8.6 Kinnser Software Inc
8.7 Linde Group
8.8 Omron Corporation
8.9 Roche Holding AG
8.10 Philips Healthcare
8.11 Mckesson Corporation
8.12 LHC Group Inc
8.13 Kindred Healthcare
8.14 Fresenius Se & Co Kgaa
8.15 Abbott Laboratories
8.16 Apria Healthcare Group.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
